(S)-2-(4-Fluorophenyl)-3-methylbutanoic acid, 97%, 1g

4-Bromo-7-chloroisoquinolin-1(2H)-one, 95.0%, 250mg

"[S(R)]-N-((1S)-(Adamantan-1-yl)(5-(diphenylphosphanyl)-9,9-dimethyl-9H- xanthen-4-yl)methyl)-2-methyl-2-propanesulfinamide", 95%, 25mg

4-bromo-5-methoxy-2-methylpyridine, 95.0%, 500mg

N-(((9H-Fluoren-9-yl)methoxy)carbonyl)-O-ethyl-N-methyl-L-serine, 98%, 1g

tert-Butyl 14-(tosyloxy)-3,6,9,12-tetraoxatetradecan-1-oate, 95%, 100mg

1-Methyl-1H-indol-3-yl butyrate, 95+%, 1g

HPLC column NUCLEODUR® 300-5 C4 ec, 250 mm, 4 mm, 1 Piece(s)

2,2'-Oxybis(ethylamine)>98.0%(GC)(T)1g

2-Methyl-1H-indazole-6-boronic acid, 95.0%, 250mg

4-chlorobutanal, 95.0%, 1g

5-Chloro-2-(piperidin-4-yl)pyrimidine hydrochloride, 95+%, 1g

(2-phenyl-1H-imidazol-1-yl)acetic acid acetate, 95.0%, 1g